Cardiac morphogenesis and function are known to depend on both aerobic and anaerobic energy-producing pathways. However, the relative contribution of mitochondrial oxidation and glycogenolysis, as well as the determining factors of oxygen demand in the distinct chambers of the embryonic heart, remains to be investigated. Spontaneously beating hearts isolated from stage 11, 20, and 24HH chick embryos were maintained in vitro under controlled metabolic conditions. O 2 uptake and glycogenolytic rate were determined in atrium, ventricle, and conotruncus in the absence or presence of glucose. Oxidative capacity ranged from 0.2 to 0.5 nmol O 2 /(h⅐g protein), did not depend on exogenous glucose, and was the highest in atria at stage 20HH. However, the highest reserves of oxidative capacity, assessed by mitochondrial uncoupling, were found at the youngest stage and in conotruncus, representing 75 to 130% of the control values. At stage 24HH, glycogenolysis in glucose-free medium was 0.22, 0.17, and 0.04 nmol glucose U(h⅐g protein) in atrium, ventricle, and conotruncus, respectively. Mechanical loading of the ventricle increased its oxidative capacity by 62% without altering glycogenolysis or lactate production. Blockade of glycolysis by iodoacetate suppressed lactate production but modified neither O 2 nor glycogen consumption in substrate-free medium. These findings indicate that atrium is the cardiac chamber that best utilizes its oxidative and glycogenolytic capacities and that ventricular wall stretch represents an early and major determinant of the O 2 uptake. Moreover, the fact that O 2 and glycogen consumptions were not affected by inhibition of glyceraldehyde-3-phosphate dehydrogenase provides indirect evidence for an active glycerol-phosphate shuttle in the embryonic cardiomyocytes. The embryonic/fetal heart operates and develops normally in a relatively hypoxic microenvironment and shows both aerobic and anaerobic energy-producing capacities. In such a heart, by contrast with the adult, mitochondria convert fatty acids to energy at a very low rate (1), whereas glycolysis contributes significantly to ATP production (2, 3) and glycogen turnover is rapid (4). Such metabolic features confer a benefit to the developing heart, because glucose requires less O 2 than fatty acids to produce a given amount of ATP, which is advantageous specially when O 2 availability is limited (5, 6).The embryonic myocardium (7-9) displays also a glycogen concentration 10 -20-fold higher than in the adult (3) and can tolerate a transient depletion of exogenous substrates in normoxia (10) or even recover rapidly from substrate-free anoxic episodes (11,12). Similar characteristics are found in fetal and neonatal hearts (13)(14)(15). However, in avian embryos (16) and mammalian fetuses (17), the cardiovascular response to O 2 lack is very rapid despite important glycolytic capacities, indicating that under physiologic conditions, the embryonic/ fetal heart works at the upper limit of its function curve. Indeed, during early development, ...